Chris Price is a healthcare investor focused on tech-enabled services for payers, providers. See sector focus and contact routes.
Chris Price is a healthcare investor focused on tech-enabled services for payers, providers, and pharmaceutical companies that improve clinical, financial, and experiential outcomes[1][9]. He leads Epilog Partners, which targets $50–$200 million leveraged buyouts of profitable, high-growth healthcare businesses using a research-centric, thesis-driven approach[3][9]. His notable portfolio includes CareConnectors Medical Group (acquired in 2024), CareMetx, and the exited ReceptRx[2][3]. Price’s distinctive thesis centers on transforming healthcare into a people-focused, sustainable system by investing in pharma services for complex therapies, risk-bearing care models, and workflow optimization solutions[1][3].
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Dallas.
Investors like Chris Price · Full investor directory · Investor access · Company funding database